Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Phospho-RIPK1 (Ser161) Mouse anti-Human, Unconjugated, Clone: 1B2G1, Proteintech 

Phospho-RIPK1 (Ser161) Mouse anti-Human, Unconjugated, Clone: 1B2G1, Proteintech
SDP

Catalog No. 502239053 Shop All Proteintech Group Inc Products
Encompass
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-223-9053 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 50-223-9053 Supplier Proteintech Group Inc Supplier No. 668541IG100UL
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

The Phospho-RIPK1 (Ser161) antibody from Proteintech is a mouse monoclonal antibody generated with peptide of human Phospho-RIPK1 (Ser161) . This antibody recognizes human antigen. The Phospho-RIPK1 (Ser161) antibody has been validated for the following applications: IF, IHC, WB, ELISA analysis.

Specifications

Antigen Phospho-RIPK1 (Ser161)
Applications Western Blot, Immunohistochemistry, Immunofluorescence
Classification Monoclonal
Clone 1B2G1
Concentration 1468 μg/mL
Conjugate Unconjugated
Host Species Mouse
Quantity 100 μL
Primary or Secondary Primary
Gene ID (Entrez) 8737
Target Species Human
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.